Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival-Reference-Cited by-同舟云学术

Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival

Published:2010-11-02 Issue:2 Volume:50 Page:278-282
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Moura R. A.,Cascao R.,Perpetuo I.,Canhao H.,Vieira-Sousa E.,Mourao A. F.,Rodrigues A. M.,Polido-Pereira J.,Queiroz M. V.,Rosario H. S.,Souto-Carneiro M. M.,Graca L.,Fonseca J. E.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/50/2/278/5055068/keq338.pdf

Reference20 articles.

1. Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study

2. Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

3. Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

4. Alterations on peripheral blood B-cell subpopulations in very early arthritis patients

5. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy;Renal Failure;2024-08-14

2. Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy;2024-02-28

3. A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence;Journal of Clinical Medicine;2023-11-04

4. Children with extended oligoarticular and polyarticular juvenile idiopathic arthritis have alterations in B and T follicular cell subsets in peripheral blood and a cytokine profile sustaining B cell activation;RMD Open;2023-08

5. Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis;Inflammation;2023-03-10